Methodological notes by company and year
Methodological Notes by Year / Company
Every company disclosing data on Disclosure UK about healthcare professionals (HCPs), other relevant decision makers (ORDMs), and healthcare organisations (HCOs) has provided a Methodological Note which explains how they compiled their data. Please ensure that you consider these notes when you are exploring the data.
To download a full HCP, ORDM and HCO dataset for each year, please visit the Disclosure UK search.
A. MENARINI |
2024 2023 2022 |
ABBVIE |
2024 2023 2022 |
||
ACCORD |
2024 2023 2022 |
ADVANZ PHARMA | - - 2022 |
||
ADVANZ UK & IRE | 2024 2023 2022 |
AGB |
2024 2023 - |
||
AGUETTANT |
2024 2023 2022 |
ALEXION |
2024 2023 2022 |
||
ALFASIGMA |
2024 - - |
ALIMERA SCIENCES |
2024 2023 2022 |
||
ALK-ABELLO |
2024 2023 2022 |
ALLERGAN |
- - 2022 |
||
ALLIANCE |
2024 2023 2022 |
ALMIRALL |
2024 2023 2022 |
||
ALNYLAM |
2024 2023 2022 |
ALTURIX |
2024 2023 2022 |
||
AMARIN |
2024 2023 2022 |
AMGEN |
2024 2023 2022 |
||
AMICUS THERAPUTICS |
2024 2023 2022 |
AMRYT |
- 2023 2022 |
||
ANGELINI |
2024 2023 2022 |
ASCENDIS |
2024 - - |
||
ASPEN |
2024 - - |
ASTELLAS |
2024 2023 2022 |
||
ASTRAZENECA |
2024 2023 2022 |
ATNAHS |
2024 2023 2022 |
||
BAUSCH & LOMB |
2024 2023 2022 |
BAXTER HEALTHCARE |
2024 2023 2022 |
||
BAYER |
2024 2023 2022 |
BESINS HEALTHCARE |
2024 2023 2022 |
||
BIAL |
2024 2023 2022 |
BIO PRODUCTS LABORATORY |
2024 2023 2022 |
||
BIOCRYST |
2024 2023 2022 |
BIOGEN IDEC |
2024 2023 2022 |
||
BIOMARIN EUROPE |
2024 2023 2022 |
BIOPROJET |
2024 2023 2022 |
||
BLUE EARTH DIAGNOSTICS |
2024 2023 2022 |
BOEHRINGER INGELHEIM |
2024 2023 2022 |
||
BRACCO |
2024 2023 2022 |
BRISTOL-MYERS SQUIBB |
2024 2023 2022 |
||
BRITANNIA |
2024 2023 2022 |
CAMURUS |
2024 2023 2022 |
||
CELLTRION HEALTHCARE |
2024 2023 2022 |
CHIESI |
2024 2023 2022 |
||
CHUGAI |
2024 2023 2022 |
CIPLA |
2024 2023 2022 |
||
CLINUVEL |
2024 2023 2022 |
CNX THERAPEUTICS |
2024 - 2022 |
||
CONSILIENT HEALTH |
2024 2023 2022 |
CROMA |
2024 2023 2022 |
||
CSL BEHRING |
2024 2023 2022 |
DAIICHI SANKYO |
2024 2023 2022 |
||
DERMAL LABORATORIES |
2024 2023 2022 |
DIURNAL |
2024 2023 2022 |
||
DR FALK |
2024 2023 2022 |
EISAI |
2024 2023 2022 |
||
ELI LILLY |
2024 2023 2022 |
ESTEVE |
2024 - - |
||
ETHYPHARM GROUP |
2024 2023 2022 |
EVER |
2024 2023 2022 |
||
EXELTIS |
2024 2023 2022 |
FERRING |
2024 2023 2022 |
||
FLYNN |
2024 2023 2022 |
FRESENIUS MEDICAL CARE |
2024 2023 2022 |
||
FRESENIUS KABI |
2024 2023 2022 |
GALAPAGOS BIOTECH |
- 2023 2022 |
||
GALEN |
2024 2023 2022 |
GE HEALTHCARE |
2024 2023 2022 |
||
GEDEON RICHTER |
2024 2023 2022 |
GILEAD |
2024 2023 2022 |
||
GLAXOSMITHKLINE |
2024 2023 2022 |
GRUNENTHAL |
2024 2023 2022 |
||
GUERBET |
2024 2023 2022 |
HRA |
2024 2023 2022 |
||
IBSA |
2024 2023 - |
IDORSIA |
2024 2023 2022 |
||
IMMEDICA |
2024 2023 2022 |
INCYTE | 2024 - - |
||
INDIVIOR |
2024 2023 2022 |
INTERCEPT |
- - 2022 |
||
IPSEN |
2024 2023 2022 |
IQVIA IES |
2024 2023 2022 |
||
JANSSEN-CILAG (J&J CO) |
2024 - - |
JANSSEN-CILAG |
- 2023 2022 |
||
JAZZ |
2024 2023 2022 |
KORA |
2024 2023 2022 |
||
L.D. COLLINS |
2024 2023 2022 |
LEADIANT BIOSCIENCES |
2024 2023 2022 |
||
LEO |
2024 2023 2022 |
LUNDBECK |
2024 2023 2022 |
||
LUPIN |
2024 2023 2022 |
LUYE |
2024 - - |
||
MEDICE |
2024 2023 2022 |
MENARINI STEMLINE |
2024 2023 - |
||
MERCK SERONO |
2024 2023 2022 |
MERCK SHARP & DOHME |
2024 2023 2022 |
||
MERZ |
2024 2023 2022 |
MITSUBISHI TANABE |
2024 2023 2022 |
||
MODERNA | 2024 2023 2022 |
MUNDIBIOPHARMA |
- - 2022 |
||
MUNDIPHARMA MEDICAL |
2024 2023 2022 |
MUNDIPHARMA RESEARCH |
2024 2023 2022 |
||
NAPP |
2024 2023 2022 |
NEON HEALTHCARE | 2024 2023 2022 |
||
NEURAXPHARM |
2024 2023 2022 |
NORGINE |
2024 2023 2022 |
||
NOVARTIS |
2024 2023 2022 |
NOVO NORDISK |
2024 2023 2022 |
||
OCTAPHARMA |
2024 2023 2022 |
ORGANON |
2024 2023 2022 |
||
ORION |
2024 2023 2022 |
ORPHALAN |
2024 2023 2022 |
||
OTSUKA |
2024 2023 2022 |
OUTLOOK |
2024 - - |
||
PACIRA BIOSCIENCES | 2024 2023 2022 |
PAION |
2024 2023 2022 |
||
PARI MEDICAL |
2024 2023 2022 |
PFIZER |
2024 2023 2022 |
||
PIRAMAL CRITICAL CARE |
2024 - - |
PHARMAMAR |
- 2023 2022 |
||
PHARMASURE |
- - 2022 |
PHARMA NORD |
2024 2023 - |
||
PIERRE FABRE |
2024 2023 2022 |
PROFILE |
- - 2022 |
||
PROVECA |
2024 2023 2022 |
PROVEPHARM |
2024 - - |
||
PTC THERAPEUTICS |
2024 2023 2022 |
RECKITT |
2024 2023 2022 |
||
RECORDATI UK | 2024 - - |
RECORDATI |
2024 2023 2022 |
||
RECORDATI RARE DISEASES |
2024 2023 2022 |
REGENERON |
2024 2023 2022 |
||
RHYTHM |
2024 2023 - |
ROCHE |
2024 2023 2022 |
||
ROSEMONT |
2024 2023 2022 |
SAMSUNG BIOEPIS |
2024 2023 - |
||
SANOFI AVENTIS |
2024 2023 2022 |
SANTEN |
2024 2023 2022 |
||
SANTHERA |
2024 - - |
SEQIRUS |
2024 2023 2022 |
||
SERVIER |
2024 2023 2022 |
SHIONOGI BV |
2024 2023 2022 |
||
SIFI |
2024 2023 2022 |
SOBI |
2024 2023 2022 |
||
STALLERGENES GREER |
2024 - - |
STD PRODUCTS |
- 2023 - |
||
STIRLING ANGLIAN |
2024 2023 2022 |
SUN |
2024 2023 - |
||
SYNER-MED |
2024 2023 2022 |
SYRI |
- 2023 2022 |
||
TAKEDA |
2024 2023 2022 |
TETRIS |
2024 - 2022 |
||
TEVA |
2024 2023 2022 |
THEA |
2024 2023 2022 |
||
THERAMEX |
2024 - - |
THERATECHNOLOGIES |
- - 2022 |
||
TILLOTTS |
2024 2023 2022 |
UCB |
2024 2023 2022 |
||
VALNEVA |
2024 2023 2022 |
VERITON |
2024 2023 2022 |
||
VIFOR GROUP |
2024 2023 2022 |
VISUFARMA |
2024 2023 - |
||
ZAMBON |
2024 2023 2022 |
Last modified: 14 July 2025
Last reviewed: 14 July 2025